Inhibiting a specific protein complex in SARS-CoV-2, the virus that causes COVID-19, may be a promising therapeutic target for treating the disease, according to a Northwestern Medicine study.
Boosting mitochondrial function in a subpopulation of T cells could make cancer immunotherapy more effective, according to a recent study.
Listen to the year’s most popular episodes of the Breakthroughs podcast, featuring Northwestern Medicine experts discussing COVID-19 research.
A viral protein of the Epstein-Barr virus previously thought to mimic immune cell receptor signaling actually rewires intracellular signaling in infected cells, promoting viral cell survival and proliferation.
Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
Using an artificial intelligence cell classification technique, Northwestern Medicine investigators have found that viruses can control structural and genetic polarity inside the cell nucleus.
A specialized subset of rare immune cells called plasmacytoid dendritic cells may promote antitumor immunity, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
A new potential drug target has been identified in SARS CoV-2 – the virus that causes COVID-19 – by scientists who say multiple drugs will likely be needed to respond to the pandemic.
Gold-plated nanocrystals could help rebuild nerves damaged by multiple sclerosis, according to a recent study.
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).